drugset
drugset / Trial / NCT00879879

Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis

NCT00879879 ↗

Completed 20 enrolled University of South Florida National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Losartan may be effective in treating patients with idiopathic pulmonary fibrosis. PURPOSE: This clinical trial is studying the side effects of losartan and to see how well it works in treating patients with idiopathic pulmonary fibrosis.

Timeline

Start
2009-03
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Losartan Other / unclassified 50 mg Oral

Indications

precancerous condition